Table 3 Common medications prescribed for patients with a venous thromboembolic event (VTEE) or atrial fibrillation (AF)
From: Characteristics of patients with venous thromboembolism and atrial fibrillation in Venezuela
| Â | VTEE (n = 401) | AF (n = 996) | ||
|---|---|---|---|---|
| Â | n | % | n | % |
Anticoagulant used | Â | Â | Â | Â |
   Dalteparin sodium | 12 | 3.0% | 24 | 2.4% |
   Enoxaparin | 264 | 65.8% | 476 | 47.8% |
   Heparin sodium | 159 | 39.7% | 32 | 3.2% |
   Warfarin sodium | 271 | 67.6% | 323 | 32.4% |
Class of Concomitant Medications | Â | Â | Â | Â |
   Antiarrhythmic drugs | 38 | 9.5% | 831 | 83.4% |
   Proton-pump inhibitors | 151 | 37.7% | 293 | 29.4% |
   Benzodiazepines | 119 | 29.7% | 312 | 31.3% |
   H2 blockers | 131 | 32.7% | 239 | 24.0% |
   Diuretics | 22 | 5.5% | 248 | 24.9% |
   Antiplatelet drugs | 51 | 12.7% | 188 | 18.9% |
   Angiotensin-converting enzyme inhibitor | 27 | 6.7% | 208 | 20.9% |
   Beta blockers | 25 | 6.2% | 156 | 15.7% |
   Aldosterone receptor antagonists | 15 | 3.7% | 141 | 14.2% |
   Nonsteroidal anti-inflammatory medications | 66 | 16.5% | 73 | 7.3% |
   Salicylates | 17 | 4.2% | 85 | 8.5% |
   Quinolone antibiotics | 31 | 7.7% | 54 | 5.4% |
   Calcium antagonist | 9 | 2.2% | 71 | 7.1% |
   Cephalosporins | 44 | 11.0% | 26 | 2.6% |